| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/24/2011 | US20110071088 Method for treating neurological disorders |
| 03/24/2011 | US20110071087 Polypeptides having modulatory effects on cells |
| 03/24/2011 | US20110071086 Compositions for tissue repair/regeneration |
| 03/24/2011 | US20110071085 Use of survivin to treat kidney failure |
| 03/24/2011 | US20110071084 Benzazepine derivatives useful as vasopressin antagonists |
| 03/24/2011 | US20110071083 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 03/24/2011 | US20110071082 Long lasting anti-angiogenic peptides |
| 03/24/2011 | US20110071081 Methods useful in the treatment of bone resorption diseases |
| 03/24/2011 | US20110071080 Methods and compositions for sleep disorders and other disorders |
| 03/24/2011 | US20110071079 Self-assembling poly(diol citrates)-protein hydrogels |
| 03/24/2011 | US20110071078 Methods for treating neurological deficits |
| 03/24/2011 | US20110071077 Thrombopoietic Compounds |
| 03/24/2011 | US20110071076 Novel exendin agonist compounds |
| 03/24/2011 | US20110071075 Promoter for bicarbonate secretion in gastrointestinal tract |
| 03/24/2011 | US20110071074 Deuterated hepatitis c protease inhibitors |
| 03/24/2011 | US20110071073 Detection of mutations in a gene associated with resistance to viral infection, OAS1 |
| 03/24/2011 | US20110071072 Antifungal Bone Cements |
| 03/24/2011 | US20110071071 Psmb10: a diagnosis marker and therapeutic target of chronic rejection |
| 03/24/2011 | US20110070311 Producing a sustained-release preparation |
| 03/24/2011 | US20110070296 Topical compositions and methods for utilizing peptides containing lipid-modified cysteine-containing peptides |
| 03/24/2011 | US20110070294 Methods for the Administration of Drugs Using Liposomes |
| 03/24/2011 | US20110070293 Methods for the Preparation of Liposomes Comprising Docetaxel |
| 03/24/2011 | US20110070292 Methods For The Preparation Of Liposomes |
| 03/24/2011 | US20110070288 Composite layered hemostasis device |
| 03/24/2011 | US20110070287 Film-Coated Compressed Chewing Gum |
| 03/24/2011 | US20110070276 Bioactive keratin peptides |
| 03/24/2011 | US20110070272 Materials and Methods for Modulating Metabolism |
| 03/24/2011 | US20110070271 Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| 03/24/2011 | US20110070270 Immunostimulating agent |
| 03/24/2011 | US20110070269 Lipopolysaccharide isolated from pyrularia tissue and/or pyrularia-associated bacteria and uses thereof |
| 03/24/2011 | US20110070255 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 03/24/2011 | US20110070253 Tumour-associated peptides binding to mhc molecules |
| 03/24/2011 | US20110070251 Cancer vaccine composition |
| 03/24/2011 | US20110070242 Methods for Diagnosing and Treating Iron Dysregulation |
| 03/24/2011 | US20110070240 Methods of treating b-cell cancers |
| 03/24/2011 | US20110070237 Methods of modulating and identifying agents that modulate intracellular calcium |
| 03/24/2011 | US20110070224 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 03/24/2011 | US20110070222 Therapeutic Modulation of Ocular Surface Lubrication |
| 03/24/2011 | US20110070220 Immunomodulating gene therapy |
| 03/24/2011 | US20110070219 High pressure protein crystallization |
| 03/24/2011 | US20110070218 Methods of treating cancer of the central nervous system |
| 03/24/2011 | US20110070217 Compositions and methods for treating hiv infection with cupredoxin and cytochrome c |
| 03/24/2011 | US20110070216 Therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes |
| 03/24/2011 | US20110070215 Methods of treating cancer using neurotrophin retargeted endopeptidases |
| 03/24/2011 | US20110070212 Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopeptidases |
| 03/24/2011 | US20110070211 Methods of Treating Cancer Using Galanin Retargeted Endopepidases |
| 03/24/2011 | US20110070198 Plant-based biocidal materials and systems |
| 03/24/2011 | US20110070197 Hepatitis c virus inhibitors |
| 03/24/2011 | US20110070196 Hepatitis c virus inhibitors |
| 03/24/2011 | US20110070195 Uses of spatial configuration to modulate protein function |
| 03/24/2011 | US20110070194 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 03/24/2011 | US20110070193 Anti-Infective Agents and Uses Thereof |
| 03/24/2011 | US20110070192 Method of preparation of novel nucleoside analogs and uses |
| 03/24/2011 | US20110070191 T cell receptor fusions and conjugates and methods of use there of |
| 03/24/2011 | US20110070190 Heterocyclic antiviral compounds |
| 03/24/2011 | US20110070189 Heterocyclic antiviral compounds |
| 03/24/2011 | US20110070188 Bab triblock polymers having improved release characteristics |
| 03/24/2011 | US20110070187 Methods for the Preparation of HCV Polymerase Inhibitors |
| 03/24/2011 | US20110070186 Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases |
| 03/24/2011 | US20110070185 Identification of antigenic peptides from multiple myeloma cells |
| 03/24/2011 | US20110070184 Methods and compositions for treating atherosclerosis and related condidtions |
| 03/24/2011 | US20110070168 Macrocyclic peptides as inhibitors of viral replication |
| 03/24/2011 | US20110070167 Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants |
| 03/24/2011 | US20110070162 Rna interference mediating small rna molecules |
| 03/24/2011 | US20110070156 Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy |
| 03/24/2011 | US20110070155 Anti-CD74 Immunoconjugates and Methods |
| 03/24/2011 | CA2774593A1 Oxytocin receptor agonists |
| 03/24/2011 | CA2774556A1 Stabilized liquid and lyophilized adamts13 formulations |
| 03/24/2011 | CA2774495A1 Implant devices that differ by release profile and methods of making and using same |
| 03/24/2011 | CA2774460A1 Inhibition of endosomal toll-like receptor activation |
| 03/24/2011 | CA2774350A1 Novel peptides isolated from spider venom, and uses thereof |
| 03/24/2011 | CA2774269A1 Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency |
| 03/24/2011 | CA2773935A1 Peptides for the treatment of oxidative stress related disorders |
| 03/24/2011 | CA2773744A1 Methods of treating a patient receiving a cardiac stent implant |
| 03/24/2011 | CA2773596A1 Modified erythropoietin to which water-soluble long-chain molecule is added |
| 03/24/2011 | CA2772968A1 Advantageous mu-opiate receptor peptide compounds |
| 03/24/2011 | CA2746115A1 Medicinal products for the treatment of blood coagulation disorders |
| 03/23/2011 | EP2299272A2 N-terminally truncated HER-2/NEU protein as a cancerprognostic indicator |
| 03/23/2011 | EP2299265A1 Cancer eradication program |
| 03/23/2011 | EP2298890A1 Chinese hamster apoptosis-related genes |
| 03/23/2011 | EP2298889A1 Chinese hamster apoptosis-related genes |
| 03/23/2011 | EP2298888A1 Chinese hamster apoptosis-related genes |
| 03/23/2011 | EP2298887A1 Chinese hamster apoptosis-related genes |
| 03/23/2011 | EP2298878A2 Compositions and methods for the diagnosis of cancer |
| 03/23/2011 | EP2298877A1 Compounds for immunotherapy of prostate cancer and methods for their use |
| 03/23/2011 | EP2298874A1 Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 03/23/2011 | EP2298816A2 Apoptosis induced by an antibody against Her2 |
| 03/23/2011 | EP2298808A1 Anti-C5 antibodies and their therapeutic uses |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298801A1 Glycosylated glp-1 peptide |
| 03/23/2011 | EP2298800A1 Sclerostin binding antibodies |
| 03/23/2011 | EP2298799A1 A gene encoding a multidrug resistance human p-glyoprotein homologue on chromosome 7p15-21 and uses thereof |
| 03/23/2011 | EP2298796A2 Staphylococcus aureus proteins and nucleic acids |
| 03/23/2011 | EP2298795A1 Immunogens from uropathogenic escherichia coli |
| 03/23/2011 | EP2298793A2 Polypeptide fragments of hepatitis E virus, vaccine composition comprising said fragments and diagnostic kits |
| 03/23/2011 | EP2298792A2 Peptides targeted to protein kinase C isoforms and uses thereof |
| 03/23/2011 | EP2298790A1 Daptomycin analogs as antibacterial agents |
| 03/23/2011 | EP2298789A1 Mammalian genes; related reagents and methods |
| 03/23/2011 | EP2298358A1 Methods for delivery of nucleic acids |
| 03/23/2011 | EP2298357A1 Compositions and methods for regulated protein expression in gut |